This inventor holds 1 USPTO granted patent. Top assignee: Celgene Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Min Cao - Innovator in MK2 Inhibitors
Introduction
Min Cao is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of MK2 inhibitors. His work has led to the filing of a patent that showcases his innovative approach to addressing medical challenges.
Latest Patents
Min Cao holds a patent titled "MK2 Inhibitors and Uses Thereof." This patent represents his commitment to advancing therapeutic options and highlights his expertise in the pharmaceutical industry. He has 1 patent to his name, reflecting his innovative contributions.
Career Highlights
Min Cao is currently employed at Celgene Corporation, a leading biopharmaceutical company. His role at Celgene allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His dedication to innovation is evident in his work and the impact it has on the industry.
Collaborations
Throughout his career, Min Cao has collaborated with talented individuals such as Xirui Hu and Lixin Qiao. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the development of new solutions in the field.
Conclusion
Min Cao is a distinguished inventor whose work on MK2 inhibitors has the potential to make a significant impact in the pharmaceutical industry. His contributions, along with his collaborations, underscore the importance of innovation in addressing medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
